US Patent Litigations are now available. Check here

Explore Astrazeneca Uk's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2498759Aug 1, 2018Immediate Release Tablet Formulations4
EP2498758Jul 25, 2018Bilayer Tablet Formulations1